Name | Ilorasertib hydrochloride |
---|
Description | Ilorasertib hydrochloride (ABT-348 hydrochloride) is a potent and ATP-competitive multitargeted kinase inhibitor, which inhibits Aurora C, Aurora B, and Aurora A with IC50s of 1 nM, 7 nM, 120 nM, respectively. Ilorasertib hydrochloride (ABT-348 hydrochloride) also suppresses RET tyrosine kinase, PDGFRβ and Flt1 with IC50s of 7 nM, 3 nM and 32 nM, respectively[1]. |
---|---|
Related Catalog | |
Target |
Aurora C:1 nM (IC50) Aurora B:7 nM (IC50) Aurora B (Y156H):12 nM (IC50) Aurora A:120 nM (IC50) PDGFRα:11 nM (IC50) PDGFRβ:13 nM (IC50) VEGFR1:1 nM (IC50) VEGFR2:2 nM (IC50) VEGFR3:43 nM (IC50) FLT3:1 nM (IC50) CSF-1R:3 nM (IC50) c-KIT:20 nM (IC50) |
References |
Molecular Formula | C25H22ClFN6O2S |
---|---|
Molecular Weight | 525.00 |